Responses
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
FRI0185 In rheumatoid arthritis patients with stable low disease activity on methotrexate plus etanercept, continuation of etanercept at 50 mg or 25 mg weekly are both clinically superior to discontinuation: results from a randomized, 3-arm, double-blind study
Compose a Response to This Article
Other responses
No responses have been published for this article.